首页 | 本学科首页   官方微博 | 高级检索  
     


Proportion of CD34+CD38−CD123+ Leukemia Stem Cells at Diagnosis Varies in ELN Risk Groups and an Emerging Novel Marker for Prognosticating the Intermediate Risk patients of Acute Myeloid Leukemia: A Prospective Study
Authors:Priyanka Mishra  Seema Tyagi  Rahul Sharma  Rohan Halder  Hara P. Pati  Renu Saxena  Manoranjan Mahapatra
Affiliation:Department of Hematology, All India Institute of Medical Sciences, New Delhi, India 110049
Abstract:
Keywords:Leukemia stem cells   Aml   Prognosis   Induction remission   Relapse
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号